Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin vs Rosuvastatin/Ezetimibe in Cardiovascular Diseases
NCT07313124Phase 3Completed
- Sponsor
- Beni Suef University
- Start
- Dec 2024
- Primary completion
- Nov 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin, ezetimibe in cardiovascular disease (CVD), dyslipidemia, sponsored by Beni Suef University. Started Dec 2024; status: completed.
02
Drugs
rosuvastatinezetimibe
03
Conditions
cardiovascular disease (CVD)dyslipidemia
Beyond the preview
Go deeper on NCT07313124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07313124.